Harrow Health (HROW) Misses Q3 EPS by 15c, Misses on Revenue; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: HROW) | Delayed: 28.75 +0.21 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.54 | 52 Week High | $ | |||
| Open | $28.41 | 52 Week Low | $ | |||
| Day High | $29.54 | P/E | N/A | |||
| Day Low | $28.38 | EPS | $ | |||
| Volume | 778,033 | |||||
